Kinase requirements in human cells

II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells

Amy Baldwin, Wenliang Li, Miranda Grace, Joseph Pearlberg, Ed Harlow, Karl Münger, Dorre A. Grueneberg

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Human papillomavirus (HPV) oncoproteins subvert cellular signaling pathways, including kinase pathways, during the carcinogenic process. To identify kinases targeted by the HPV16 E7 oncoprotein, shRNA kinase screens were performed in RKO colorectal carcinoma cell lines that differ only in their expression of HPV16 E7. Our screens identified kinases that were essential for the survival of RKO cells, but not essential for RKO cells expressing HPV16 E7. These kinases include CDK6, ERBB3, FYN, AAK1, and TSSK2. We show that, as predicted, CDK6 knockdown inhibits pRb phosphorylation and induces S-phase depletion, thereby inhibiting cell viability. Knockdown of ERBB3, FYN, AAK1, and TSSK2 induces a similar loss of cell viability through an unknown mechanism. Expression of the HPV16 E7 oncoprotein, known to bind and degrade pRb, relieves the requirement of these kinases. These studies demonstate that expression of a single oncoprotein can dramatically alter kinase sensitivity in human cells. The shRNA screens used here perform analogously to genetic interaction screens commonly used in genetically tractable organisms such as yeast, and thus represent an exciting method for unbiased identification of cellular signaling pathways targeted by cancer mutations.

Original languageEnglish (US)
Pages (from-to)16478-16483
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume105
Issue number43
DOIs
StatePublished - Oct 28 2008
Externally publishedYes

Fingerprint

Phosphotransferases
Oncogene Proteins
Neoplasms
Cell Survival
Small Interfering RNA
S Phase
Colorectal Neoplasms
Yeasts
Phosphorylation
Cell Line
Mutation

Keywords

  • E7 oncoprotein
  • Essential kinases
  • Retinoblastoma tumor suppressor
  • shRNA screening

ASJC Scopus subject areas

  • General

Cite this

Kinase requirements in human cells : II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. / Baldwin, Amy; Li, Wenliang; Grace, Miranda; Pearlberg, Joseph; Harlow, Ed; Münger, Karl; Grueneberg, Dorre A.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 43, 28.10.2008, p. 16478-16483.

Research output: Contribution to journalArticle

Baldwin, Amy ; Li, Wenliang ; Grace, Miranda ; Pearlberg, Joseph ; Harlow, Ed ; Münger, Karl ; Grueneberg, Dorre A. / Kinase requirements in human cells : II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. In: Proceedings of the National Academy of Sciences of the United States of America. 2008 ; Vol. 105, No. 43. pp. 16478-16483.
@article{f6c31bbc5da54ff0806c0093fe96a810,
title = "Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells",
abstract = "Human papillomavirus (HPV) oncoproteins subvert cellular signaling pathways, including kinase pathways, during the carcinogenic process. To identify kinases targeted by the HPV16 E7 oncoprotein, shRNA kinase screens were performed in RKO colorectal carcinoma cell lines that differ only in their expression of HPV16 E7. Our screens identified kinases that were essential for the survival of RKO cells, but not essential for RKO cells expressing HPV16 E7. These kinases include CDK6, ERBB3, FYN, AAK1, and TSSK2. We show that, as predicted, CDK6 knockdown inhibits pRb phosphorylation and induces S-phase depletion, thereby inhibiting cell viability. Knockdown of ERBB3, FYN, AAK1, and TSSK2 induces a similar loss of cell viability through an unknown mechanism. Expression of the HPV16 E7 oncoprotein, known to bind and degrade pRb, relieves the requirement of these kinases. These studies demonstate that expression of a single oncoprotein can dramatically alter kinase sensitivity in human cells. The shRNA screens used here perform analogously to genetic interaction screens commonly used in genetically tractable organisms such as yeast, and thus represent an exciting method for unbiased identification of cellular signaling pathways targeted by cancer mutations.",
keywords = "E7 oncoprotein, Essential kinases, Retinoblastoma tumor suppressor, shRNA screening",
author = "Amy Baldwin and Wenliang Li and Miranda Grace and Joseph Pearlberg and Ed Harlow and Karl M{\"u}nger and Grueneberg, {Dorre A.}",
year = "2008",
month = "10",
day = "28",
doi = "10.1073/pnas.0806195105",
language = "English (US)",
volume = "105",
pages = "16478--16483",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "43",

}

TY - JOUR

T1 - Kinase requirements in human cells

T2 - II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells

AU - Baldwin, Amy

AU - Li, Wenliang

AU - Grace, Miranda

AU - Pearlberg, Joseph

AU - Harlow, Ed

AU - Münger, Karl

AU - Grueneberg, Dorre A.

PY - 2008/10/28

Y1 - 2008/10/28

N2 - Human papillomavirus (HPV) oncoproteins subvert cellular signaling pathways, including kinase pathways, during the carcinogenic process. To identify kinases targeted by the HPV16 E7 oncoprotein, shRNA kinase screens were performed in RKO colorectal carcinoma cell lines that differ only in their expression of HPV16 E7. Our screens identified kinases that were essential for the survival of RKO cells, but not essential for RKO cells expressing HPV16 E7. These kinases include CDK6, ERBB3, FYN, AAK1, and TSSK2. We show that, as predicted, CDK6 knockdown inhibits pRb phosphorylation and induces S-phase depletion, thereby inhibiting cell viability. Knockdown of ERBB3, FYN, AAK1, and TSSK2 induces a similar loss of cell viability through an unknown mechanism. Expression of the HPV16 E7 oncoprotein, known to bind and degrade pRb, relieves the requirement of these kinases. These studies demonstate that expression of a single oncoprotein can dramatically alter kinase sensitivity in human cells. The shRNA screens used here perform analogously to genetic interaction screens commonly used in genetically tractable organisms such as yeast, and thus represent an exciting method for unbiased identification of cellular signaling pathways targeted by cancer mutations.

AB - Human papillomavirus (HPV) oncoproteins subvert cellular signaling pathways, including kinase pathways, during the carcinogenic process. To identify kinases targeted by the HPV16 E7 oncoprotein, shRNA kinase screens were performed in RKO colorectal carcinoma cell lines that differ only in their expression of HPV16 E7. Our screens identified kinases that were essential for the survival of RKO cells, but not essential for RKO cells expressing HPV16 E7. These kinases include CDK6, ERBB3, FYN, AAK1, and TSSK2. We show that, as predicted, CDK6 knockdown inhibits pRb phosphorylation and induces S-phase depletion, thereby inhibiting cell viability. Knockdown of ERBB3, FYN, AAK1, and TSSK2 induces a similar loss of cell viability through an unknown mechanism. Expression of the HPV16 E7 oncoprotein, known to bind and degrade pRb, relieves the requirement of these kinases. These studies demonstate that expression of a single oncoprotein can dramatically alter kinase sensitivity in human cells. The shRNA screens used here perform analogously to genetic interaction screens commonly used in genetically tractable organisms such as yeast, and thus represent an exciting method for unbiased identification of cellular signaling pathways targeted by cancer mutations.

KW - E7 oncoprotein

KW - Essential kinases

KW - Retinoblastoma tumor suppressor

KW - shRNA screening

UR - http://www.scopus.com/inward/record.url?scp=55949124308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55949124308&partnerID=8YFLogxK

U2 - 10.1073/pnas.0806195105

DO - 10.1073/pnas.0806195105

M3 - Article

VL - 105

SP - 16478

EP - 16483

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 43

ER -